[go: up one dir, main page]

EE200200240A - Lämmastikoksiidi kasutamine hingamisteede ahenemise raviks - Google Patents

Lämmastikoksiidi kasutamine hingamisteede ahenemise raviks

Info

Publication number
EE200200240A
EE200200240A EEP200200240A EEP200200240A EE200200240A EE 200200240 A EE200200240 A EE 200200240A EE P200200240 A EEP200200240 A EE P200200240A EE P200200240 A EEP200200240 A EE P200200240A EE 200200240 A EE200200240 A EE 200200240A
Authority
EE
Estonia
Prior art keywords
treatment
nitric oxide
airway constriction
constriction
airway
Prior art date
Application number
EEP200200240A
Other languages
English (en)
Estonian (et)
Inventor
Hjoberg Josephine
Hedenstierna G�ran
H�gman Marieann
Original Assignee
Aga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aga Ab filed Critical Aga Ab
Publication of EE200200240A publication Critical patent/EE200200240A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200200240A 1999-11-03 2000-11-02 Lämmastikoksiidi kasutamine hingamisteede ahenemise raviks EE200200240A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903985A SE9903985D0 (sv) 1999-11-03 1999-11-03 Use of nitric oxide
PCT/SE2000/002153 WO2001032202A1 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction

Publications (1)

Publication Number Publication Date
EE200200240A true EE200200240A (et) 2003-06-16

Family

ID=20417596

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200240A EE200200240A (et) 1999-11-03 2000-11-02 Lämmastikoksiidi kasutamine hingamisteede ahenemise raviks

Country Status (20)

Country Link
EP (1) EP1225913B8 (xx)
JP (1) JP2003513048A (xx)
CN (1) CN1230199C (xx)
AR (1) AR026335A1 (xx)
AT (1) ATE302023T1 (xx)
AU (1) AU778347B2 (xx)
BR (1) BR0015329A (xx)
CA (1) CA2389655A1 (xx)
CZ (1) CZ20021559A3 (xx)
DE (1) DE60022070T2 (xx)
EE (1) EE200200240A (xx)
ES (1) ES2248153T3 (xx)
HU (1) HUP0203065A3 (xx)
IL (1) IL149170A0 (xx)
MX (1) MXPA02004069A (xx)
NO (1) NO20022113D0 (xx)
PL (1) PL354653A1 (xx)
SE (1) SE9903985D0 (xx)
WO (1) WO2001032202A1 (xx)
ZA (1) ZA200203391B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
US6601580B1 (en) 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
ATE310514T1 (de) 2002-04-19 2005-12-15 Yissum Res Dev Co Beta-agonisten-verbindungen mit stickoxid- donatoren-gruppen und reaktionsfähige sauerstoffspezies-fängergruppen und ihre verwendung bei der behandlung von atemwegsstörungen
PL375161A1 (en) * 2002-06-21 2005-11-28 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
EP2359845A4 (en) * 2008-12-03 2015-05-27 Ltt Bio Pharma Co Ltd INHALANT COMPRISING A MODIFIED SUPERMEDASE SUPERMEDASE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133575T2 (de) * 1990-12-05 2008-04-17 The General Hospital Corp., Boston Verwendung von NO zur Behandlung der persistenten pulmonaren Hypertonie des Neugeborenen
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
AU6031096A (en) * 1995-06-05 1996-12-24 Duke University Nitrosylated and nitrated superoxide oxidants and reductants
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds

Also Published As

Publication number Publication date
AU778347B2 (en) 2004-12-02
WO2001032202A1 (en) 2001-05-10
JP2003513048A (ja) 2003-04-08
CA2389655A1 (en) 2001-05-10
EP1225913B8 (en) 2005-10-19
BR0015329A (pt) 2002-07-09
HUP0203065A2 (hu) 2003-01-28
IL149170A0 (en) 2002-11-10
ES2248153T3 (es) 2006-03-16
PL354653A1 (en) 2004-02-09
CZ20021559A3 (cs) 2003-05-14
ZA200203391B (en) 2002-12-20
CN1387441A (zh) 2002-12-25
AR026335A1 (es) 2003-02-05
EP1225913B1 (en) 2005-08-17
AU1745601A (en) 2001-05-14
CN1230199C (zh) 2005-12-07
NO20022113L (no) 2002-05-02
DE60022070D1 (de) 2005-09-22
HUP0203065A3 (en) 2006-07-28
EP1225913A1 (en) 2002-07-31
NO20022113D0 (no) 2002-05-02
MXPA02004069A (es) 2003-08-20
SE9903985D0 (sv) 1999-11-03
DE60022070T2 (de) 2006-03-30
ATE302023T1 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
IL196301A0 (en) Medicament for the treatment of hapatitis c
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
GB2392836B (en) Wound dressings for the treatment of wound infection
EE200300226A (et) Lämmastikoksiidi inhaleerimine
HUP0202150A3 (en) Use of nitric oxide donors for inducing neurogenesis
EP1207811A4 (en) STAIN OXIDE RELEASE MEDICAL ARTICLES
GB0004531D0 (en) The treatment of respiratory diseases
IL156139A0 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
EE200200240A (et) Lämmastikoksiidi kasutamine hingamisteede ahenemise raviks
PL367639A1 (en) Novel heterocyclic compound and medicinal use thereof
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
PL349910A1 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
GB0026923D0 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20022244D0 (no) Behandling av SLE med dehydroepiandrosteron
PT1305314E (pt) Agente terapeutico cristalino
IL151493A0 (en) Use of dermaciclane for the treatment of anxiety and depression
NO20013464D0 (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20041320L (no) Anvendelse av spesifikk dose av fondaparinux-natrium for behandling av ACS
GB0112084D0 (en) The treatment of respiratory infections
TJ11Y3 (en) The ointment "Origanolum" for treatment of wounds and calds
GB9910545D0 (en) The treatment of acarids